AU2206599A - Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists - Google Patents

Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists

Info

Publication number
AU2206599A
AU2206599A AU22065/99A AU2206599A AU2206599A AU 2206599 A AU2206599 A AU 2206599A AU 22065/99 A AU22065/99 A AU 22065/99A AU 2206599 A AU2206599 A AU 2206599A AU 2206599 A AU2206599 A AU 2206599A
Authority
AU
Australia
Prior art keywords
oximino
ant
pyrrolidine
agonists
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22065/99A
Inventor
Hwang-Hsing Chen
Abdelmoula Namil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2206599A publication Critical patent/AU2206599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22065/99A 1997-12-23 1998-12-22 Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists Abandoned AU2206599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6876197P 1997-12-23 1997-12-23
US60068761 1997-12-23
PCT/US1998/027587 WO1999032445A1 (en) 1997-12-23 1998-12-22 Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists

Publications (1)

Publication Number Publication Date
AU2206599A true AU2206599A (en) 1999-07-12

Family

ID=22084545

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22065/99A Abandoned AU2206599A (en) 1997-12-23 1998-12-22 Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists

Country Status (2)

Country Link
AU (1) AU2206599A (en)
WO (1) WO1999032445A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020256166A1 (en) 2019-04-02 2021-10-14 Aligos Therapeutics, Inc. Compounds targeting PRMT5

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
AU7528696A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine antagonists
AU7478396A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine agonists

Also Published As

Publication number Publication date
WO1999032445A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU5203999A (en) Beta3-adrenergic receptor agonists
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
AU2001290250A1 (en) Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
AU3932999A (en) Pyrazoline derivatives, their preparation and application as medicaments
AU2002222001A1 (en) 3-arylindole derivatives and their use as CB2 receptor agonists
AU1756897A (en) Avermectin formulation
AU8876698A (en) Phenylindole derivatives as 5-ht2a receptor ligands
AU3957900A (en) New compounds, their preparation and use
AU1939799A (en) Anti-retroviral immunogens, preparation and use
AU5049699A (en) Phenylindole derivatives as 5-HT2A receptor ligands
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
AU2619800A (en) Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
AU6348998A (en) Indole derivatives as 5-HT1 agonists
AU2095099A (en) Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
AU2203801A (en) Formulations of adenosine a1 agonists
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU8743098A (en) Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
AU8414098A (en) Noscapine derivatives, useful as anticancer agents
AU2203601A (en) Formulations of adenosine a1 agonists
AU4493496A (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU3550697A (en) Aminocyclohexane derivatives as 5-ht receptor agonists
AU3811300A (en) Sulfonamide derivatives as 5-ht7 receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase